For instance, the transcription of CYP19A1 (a gene encoding the aromatase enzyme) was downregulated in MDA-MB-231 breast cancer cells expressing aromatase following the inhibition of SIRT1 by treatment with both cambinol and inhibitor VII [52]. This evidence concerns the gene CYP19A1 and breast cancer.